Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone
James D. Lewis, Assiamira Ferrara, Tiffany Peng, et al.
Diabetes Care (2011) Vol. 34, Iss. 4, pp. 916-922
Open Access | Times Cited: 624

Showing 26-50 of 624 citing articles:

Diabetes and cancer: two diseases with obesity as a common risk factor
Satish K. Garg, Harold M. Maurer, Kristen Reed, et al.
Diabetes Obesity and Metabolism (2013) Vol. 16, Iss. 2, pp. 97-110
Open Access | Times Cited: 256
Nuclear Receptors and Their Selective Pharmacologic Modulators
Thomas P. Burris, Laura A. Solt, Yongjun Wang, et al.
Pharmacological Reviews (2013) Vol. 65, Iss. 2, pp. 710-778
Open Access | Times Cited: 253
Current efforts and trends in the treatment of NASH
Vlad Ratziu, Zachary Goodman, Arun J. Sanyal
Journal of Hepatology (2015) Vol. 62, Iss. 1, pp. S65-S75
Open Access | Times Cited: 250
Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo
Kathryn Williams, Nicholas Shackel, Mark D. Gorrell, et al.
Endocrine Reviews (2012) Vol. 34, Iss. 1, pp. 84-129
Open Access | Times Cited: 229
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
Jeffrey Johnson, Bendix Carstensen, Daniel R. Witte, et al.
Diabetologia (2012) Vol. 55, Iss. 6, pp. 1607-1618
Open Access | Times Cited: 229
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Seong Hee Kang, Hye Won Lee, Jeong‐Ju Yoo, et al.
Clinical and Molecular Hepatology (2021) Vol. 27, Iss. 3, pp. 363-401
Open Access | Times Cited: 225
Pioglitazone use and risk of bladder cancer: population based cohort study
Marco Tuccori, Kristian B. Filion, Hui Yin, et al.
BMJ (2016), pp. i1541-i1541
Open Access | Times Cited: 217
Hyperglycemia, a Neglected Factor during Cancer Progression
Wanxing Duan, Xin Shen, Jianjun Lei, et al.
BioMed Research International (2014) Vol. 2014, pp. 1-10
Open Access | Times Cited: 208
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes
Yoshifumi Saisho
World Journal of Diabetes (2015) Vol. 6, Iss. 1, pp. 109-109
Open Access | Times Cited: 206
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
Adi J. Klil‐Drori, Laurent Azoulay, Michaël Pollak
Nature Reviews Clinical Oncology (2016) Vol. 14, Iss. 2, pp. 85-99
Closed Access | Times Cited: 200
Non-alcoholic fatty liver disease: What the clinician needs to know
Mariana Verdelho Machado
World Journal of Gastroenterology (2014) Vol. 20, Iss. 36, pp. 12956-12956
Open Access | Times Cited: 199
Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy
Gadi Shlomai, Brian A. Neel, Derek LeRoith, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 35, pp. 4261-4269
Open Access | Times Cited: 195
Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
Ralph A. DeFronzo, Silvio E. Inzucchi, Muhammad Abdul-Ghani, et al.
Diabetes and Vascular Disease Research (2019) Vol. 16, Iss. 2, pp. 133-143
Open Access | Times Cited: 191
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
SV Madhu, Rajeev Chawla, B. M. Makkar, et al.
Indian Journal of Endocrinology and Metabolism (2020) Vol. 24, Iss. 1, pp. 1-1
Open Access | Times Cited: 141
PPAR-α Modulators as Current and Potential Cancer Treatments
Yan Tan, Mina Wang, Yang Ke, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 112
Pharmacotherapy of type 2 diabetes: An update and future directions
Antea DeMarsilis, Niyoti Reddy, Chrysoula Boutari, et al.
Metabolism (2022) Vol. 137, pp. 155332-155332
Closed Access | Times Cited: 98
SGLT-2 Inhibitors in Cancer Treatment—Mechanisms of Action and Emerging New Perspectives
Mieczysław Dutka, Rafał Bobiński, Tomasz Francuz, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5811-5811
Open Access | Times Cited: 73
Thiazolidinedione safety
Jacqueline Kung, Robert R. Henry
Expert Opinion on Drug Safety (2012) Vol. 11, Iss. 4, pp. 565-579
Closed Access | Times Cited: 185
Hypertriglyceridemia secondary to obesity and diabetes
Savitha Subramanian, Alan Chait
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2011) Vol. 1821, Iss. 5, pp. 819-825
Closed Access | Times Cited: 184
Should all women with PCOS be treated for insulin resistance?
John C. Marshall, Andrea Dunaif
Fertility and Sterility (2011) Vol. 97, Iss. 1, pp. 18-22
Open Access | Times Cited: 182
Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
Chia‐Hsuin Chang, Jou‐Wei Lin, Li‐Chiu Wu, et al.
Hepatology (2011) Vol. 55, Iss. 5, pp. 1462-1472
Open Access | Times Cited: 176
Polyphenols and their effects on diabetes management: A review
Naheed Aryaeian, Sara Khorshidi Sedehi, Tahereh Arablou
Medical Journal of the Islamic Republic of Iran (2017) Vol. 31, Iss. 1, pp. 886-892
Open Access | Times Cited: 162
Phytochemicals and their impact on adipose tissue inflammation and diabetes
Andreas Leiherer, Axel Mündlein, Heinz Drexel
Vascular Pharmacology (2012) Vol. 58, Iss. 1-2, pp. 3-20
Closed Access | Times Cited: 157
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial
Bruce Neal, Vlado Perkovic, David R. Matthews, et al.
Diabetes Obesity and Metabolism (2017) Vol. 19, Iss. 3, pp. 387-393
Open Access | Times Cited: 157
Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis
Isabelle N Colmers-Gray, Samantha L. Bowker, Sumit R. Majumdar, et al.
Canadian Medical Association Journal (2012) Vol. 184, Iss. 12, pp. E675-E683
Open Access | Times Cited: 152

Scroll to top